Skip to main content
CStone Pharmaceuticals logo

CStone Pharmaceuticals — Investor Relations & Filings

Ticker · 2616 ISIN · KYG2588M1006 LEI · 300300095A57F80T2461 HKEX Manufacturing
Open in API
Filings indexed 3,371 across all filing types
Latest filing 2025-03-28 Notice of Dividend Amou…
Country KY Cayman Islands
Listing HKEX 2616

About CStone Pharmaceuticals

http://www.cstonepharma.com

CStone Pharmaceuticals is an innovation-driven biopharmaceutical company focused on the research, development, and commercialization of anti-tumor drugs. The company is dedicated to addressing the unmet medical needs of cancer patients globally. Its core therapeutic focus is on innovative immuno-oncology and molecularly targeted therapies. The R&D pipeline is strategically balanced, featuring potential first-in-class or best-in-class assets, including Antibody-Drug Conjugates (ADC) and multi-specific antibodies. CStone has successfully launched four innovative drugs and secured multiple New Drug Application and indication approvals.

Recent filings

Filing Released Lang Actions
Final Dividend for the Year Ended 31 December 2024
Notice of Dividend Amount Classification · 1% confidence The document is a formal announcement of a final cash dividend for the fiscal year ended 31 December 2024, providing the dividend per share, key dates (ex‐dividend, record, payment), and related dividend details. This matches the definition of a Notice of Dividend Amount (DIV).
2025-03-28 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 1% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2025-03-28 English
CONTINUING CONNECTED TRANSACTION
Regulatory Filings Classification · 1% confidence The document is a Hong Kong stock exchange announcement regarding continuing connected transactions under Chapter 14A of the Listing Rules. It details contract terms, pricing, caps, and historical amounts for transportation services, cargo agency services, and bulk commodities sales and purchase agreements with a connected person (RGL). It is not an Annual Report, earnings release, management Q&A transcript, or any share issuance or repurchase document. It is a regulatory announcement of corporate transactions without fitting other specific categories, making it a general Regulatory Filing (RNS).
2025-03-28 English
CONNECTED TRANSACTION NON-PLANNING EXPENSES ARRANGEMENT AGREEMENTS FOR THREE SUBSIDIARIES
Regulatory Filings Classification · 1% confidence The document is a stock exchange announcement under the Hong Kong Listing Rules concerning connected (related‐party) transactions (“Connected Transaction: Non-Planning Expenses Arrangement Agreements for Three Subsidiaries”). It is not a full financial report (10-K, IR, or Annual Report), nor an earnings release, call transcript, board change, or capital raise. It contains detailed contractual terms and disclosures required by HKEX, fitting the general regulatory announcement category. There is no more specific category for connected transaction announcements, so it falls under the fallback “Regulatory Filings.”
2025-03-28 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 1% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2025-03-28 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 1% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2025-03-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.